Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 3, Issue 11, Page 2 (November 2008)


View previous. 5 of 27 View next.

EMEA Pushes Suspension of Rimonabant

JONATHAN GARDNER (London Bureau)

European regulators Oct. 23 recommended suspending the obesity drug rimonabant from the marketplace, citing risks of psychiatric disorders.

PII: S1558-0164(08)70400-0

doi:10.1016/S1558-0164(08)70400-0


View previous. 5 of 27 View next.